News

Pharmaceutical Technology on MSN1d
Merck KGaA nears $3.5bn deal for SpringWorks
Merck KGaA has confirmed that it is in late-stage discussions with SpringWorks, valuing the deal at a price of around $47 per ...
Should tariffs on pharmaceutical imports go into effect as President Trump is intimating, it would cause U.S. drug prices to ...
The transaction, which sources say could be agreed upon as soon as Monday, would price SpringWorks at $47 per share, totaling ...
Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...
AbbVie raised its 2025 profit forecast on Friday after strong sales of its newer immunology drugs Skyrizi and Rinvoq helped ...
Shares of SpringWorks Therapeutics (NASDAQ:SWTX) reached a session high on Thursday after The Wall Street Journal reported ...
The Beijing-based American Chamber of Commerce said on Friday that companies in the pharmaceutical sector had reported that ...
Medical equipment supplier and pharma services outlet Thermo Fisher Scientific also said on Wednesday it estimated a $400 ...
Core inflation in Japan's capital accelerated to a two-year high in April on surging food costs, making the central bank's ...
Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...
Erie Indemnity said on Thursday its first-quarter profit rose 11%, as the property and casualty insurer raked in higher fees from policies and earned more returns on its investments.